Pharmacological targeting of phosphodiesterase-5 halts pulmonary fibrosis by suppressing epithelial-mesenchymal transition via cGMP/PKG/Smad/HDAC2 pathway.
- DOI
- 10.1111/bph.70675
- Published
- 2026 Nov 5
- Container
- British journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bph.70675,
title = {Pharmacological targeting of phosphodiesterase-5 halts pulmonary fibrosis by suppressing epithelial-mesenchymal transition via cGMP/PKG/Smad/HDAC2 pathway.},
author = {Liu X and Gao J and Lei J and Sun J and Feng W and Zhao Z and Zhou S and Li F and Zhao AZ and Mu Y},
year = {2026},
journal = {British journal of pharmacology},
doi = {10.1111/bph.70675},
url = {https://doi.org/10.1111/bph.70675}
}RIS
TY - JOUR TI - Pharmacological targeting of phosphodiesterase-5 halts pulmonary fibrosis by suppressing epithelial-mesenchymal transition via cGMP/PKG/Smad/HDAC2 pathway. AU - Liu X AU - Gao J AU - Lei J AU - Sun J AU - Feng W AU - Zhao Z AU - Zhou S AU - Li F AU - Zhao AZ AU - Mu Y PY - 2026 JO - British journal of pharmacology DO - 10.1111/bph.70675 UR - https://doi.org/10.1111/bph.70675 ER -
APA
X, L., J, G., J, L., J, S., W, F., Z, Z., S, Z., F, L., AZ, Z., & Y, M. (2026). Pharmacological targeting of phosphodiesterase-5 halts pulmonary fibrosis by suppressing epithelial-mesenchymal transition via cGMP/PKG/Smad/HDAC2 pathway.. British journal of pharmacology. https://doi.org/10.1111/bph.70675
Source records
- pubmed · retrieved 2026-11-10T09:01:39.625Z